Sunmax Biotechnology Co., Ltd. (4728)
TWSE
Closed
Aug 25, 2026
Day's Range
399.0052 wk Range
350.00Overview - 4728 - Sunmax Biotechnology Co., Ltd.
Key Statistics
Valuation
Enterprise Value
20.45B
P/E (Trailing)
‪30.17‬
PEG Ratio
‪-41.23‬
Price / Sales (TTM)
‪10.72‬
Price / Book
‪18.41‬
EV / EBITDA
‪19.27‬
Profitability
Gross Margin
‪78.91%‬
Profit Margin
‪35.54%‬
Operating Margin
‪51.77%‬
Return on Assets
‪26.26%‬
Return on Equity
‪63.09%‬
Ownership
Shares Outstanding
54.46M
Float
27.16M
Held by Insiders
‪38.55%‬
Held by Institutions
‪0.76%‬
Price stats
Beta
‪-0.12‬
50-Day Avg
‪382.14‬
200-Day Avg
‪387.95‬
Dividends
Payout Ratio
‪178.60%‬
Frequency
Annual
Market Cap - 4728 - Sunmax Biotechnology Co., Ltd.
Peers - 4728 - Sunmax Biotechnology Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
Profile Summary - 4728 - Sunmax Biotechnology Co., Ltd.
About
Sunmax Biotechnology Co., Ltd. is a biomedical company specializing in the development, manufacturing, and commercialization of collagen-based medical devices and bio-surgical products. Established in 2001 and headquartered in Tainan, Taiwan, its core offerings focus on medical products and biomedical materials for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
